Skip to main content
    Z

    Zai Lab Ltd (ZLAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.47
    -1.13 (-4.59%)

    Market Cap: $3.07B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zai Lab Ltd (ZLAB) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Zai Lab (ZLAB) to earn -$1.88 per share in the fiscal year ending Dec 31, 2026, on revenue of $439.13M. Of 12 analysts, 11 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.92, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 92% of the ratings.

    RatingAnalystsShare
    Strong Buy216.7%
    Buy975.0%
    Hold18.3%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 22.4%.

    Fiscal year ending Dec 31, 2026
    -$1.88
    EPS consensus, revenue $439.13M
    Fiscal year ending Dec 31, 2027
    -$1.98
    EPS consensus, revenue $537.54M
    Fiscal year ending Dec 31, 2028
    -$0.92
    EPS consensus, revenue $766.99M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.88-$1.96 to -$1.795$439.13M$415.57M to $496.43M11
    Dec 31, 2027-$1.98-$3.15 to -$1.1710$537.54M$442.34M to $780.00M15
    Dec 31, 2028-$0.92-$1.41 to -$0.514$766.99M$761.42M to $772.56M11

    Quarterly Estimates

    The EPS consensus falls from -$0.06 for the quarter ending Dec 31, 2026 to -$0.44 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.06-$0.06 to -$0.064$105.62M$99.41M to $110.94M4
    Mar 31, 2027-$0.44-$0.47 to -$0.402$112.90M$112.90M to $112.90M1

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202611
    Fiscal year ending Dec 31, 202721
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.24.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.88-$2.20-$2.20-$2.20-$2.24N/A
    Fiscal year ending Dec 31, 2027-$1.98-$2.11-$2.11-$2.11-$1.98N/A
    Quarter ending Mar 31, 2027-$0.44-$0.53-$0.53-$0.53-$0.59N/A

    Frequently Asked Questions About ZLAB

    What is the ZLAB stock forecast?

    Consensus analyst estimates put Zai Lab's EPS at -$1.88 for the fiscal year ending Dec 31, 2026, on revenue of $439.13M. The consensus rating from 12 analysts is Buy.

    How do analysts rate ZLAB stock?

    Of 12 analysts covering Zai Lab, 2 rate it Strong Buy, 9 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ZLAB next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.88, with estimates from -$1.96 to -$1.79 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.98, with estimates from -$3.15 to -$1.17 from 10 analysts.

    What revenue do analysts expect from Zai Lab next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $439.13M, with estimates from $415.57M to $496.43M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $537.54M, with estimates from $442.34M to $780.00M.

    How many analysts cover ZLAB?

    12 analysts rate Zai Lab stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.